CYTEK BIOSCIENCES, INC. Marketable Securities
CYTEK BIOSCIENCES, INC. (CTKB) had Marketable Securities of $188.16 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2026-08-05
- 2026-06-30: Marketable Securities $188.16M.
- 2026-03-31: Marketable Securities $196.56M.
- 2025-12-31: Marketable Securities $170.68M.
- 2025-09-30: Marketable Securities $168.45M.
| Period end | Marketable Securities |
|---|---|
| 2026-06-30 | $188.16M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $196.56M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $170.68M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $168.45M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $186.55M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $170.31M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $179.15M 10-K · filed 2026-02-26 |
| 2024-09-30 | $115.50M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $99.32M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $101.30M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $95.11M 10-K · filed 2025-02-28 |
| 2023-09-30 | $124.39M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $167.29M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $169.52M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $44.55M 10-K · filed 2024-03-13 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |